<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/BC3595B7-7C8F-45BE-BEF2-589561222BF4"><gtr:id>BC3595B7-7C8F-45BE-BEF2-589561222BF4</gtr:id><gtr:name>Invibio</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:department>Sch of Engineering and Materials Science</gtr:department><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D5337A10-AC8A-402A-8164-C5F9CC6B0140"><gtr:id>D5337A10-AC8A-402A-8164-C5F9CC6B0140</gtr:id><gtr:name>Queen Mary, University of London</gtr:name><gtr:address><gtr:line1>Mile End Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>E1 4NS</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/BC3595B7-7C8F-45BE-BEF2-589561222BF4"><gtr:id>BC3595B7-7C8F-45BE-BEF2-589561222BF4</gtr:id><gtr:name>Invibio</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/20E66A18-4A43-4DD5-BA98-5320F6EC9269"><gtr:id>20E66A18-4A43-4DD5-BA98-5320F6EC9269</gtr:id><gtr:name>GlaxoSmithKline (GSK)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1E16D3EA-8DD1-4FDE-B49A-49FFC439A57A"><gtr:id>1E16D3EA-8DD1-4FDE-B49A-49FFC439A57A</gtr:id><gtr:name>Huxley Bertram Engineering</gtr:name><gtr:address><gtr:line1>Brookfield Centre</gtr:line1><gtr:line2>Cottenham</gtr:line2><gtr:postCode>CB24 8PS</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/304EB043-3B9D-46C7-9521-B96C2594EB6D"><gtr:id>304EB043-3B9D-46C7-9521-B96C2594EB6D</gtr:id><gtr:name>IP Group Plc</gtr:name><gtr:address><gtr:line1>24 Cornhill</gtr:line1><gtr:postCode>EC3V 3ND</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>PROJECT_PARTNER</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C0D0F832-C1E6-4258-9CA4-AD45E59C4B94"><gtr:id>C0D0F832-C1E6-4258-9CA4-AD45E59C4B94</gtr:id><gtr:firstName>Shoufeng</gtr:firstName><gtr:surname>Yang</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=EP%2FH502319%2F1"><gtr:id>3B1E3AAB-D2E6-410C-A06C-E8CA1788E272</gtr:id><gtr:title>A Dry Powder Jet Printer for Dispensing Pharmaceutical Powders.</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>EP/H502319/1</gtr:grantReference><gtr:abstractText>The specific aim of this project is to develop the QMUL technology to a bench-top powder dispensing system. The commercial product will be market ready within 2 years, providing a lower cost, more accurate system compared to competitors, such as Symyx Powdernium, FlexiWeigh and BIODOT DisPoTM. The bench-top system will act as a first step in validating the technology for scale-up to high-value applications, such as production-line filing of capsules and blisters with pharmaceutical drugs and combinatorial research. The bench-top system will be developed in partnership with Huxley Bertram Ltd, an established engineering company with expertise in designing and developing equipment for the pharmaceutical industry</gtr:abstractText><gtr:fund><gtr:end>2010-09-01</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/798CB33D-C79E-4578-83F2-72606407192C"><gtr:id>798CB33D-C79E-4578-83F2-72606407192C</gtr:id><gtr:name>EPSRC</gtr:name></gtr:funder><gtr:start>2010-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>81014</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Invibio</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>GSK</gtr:description><gtr:id>03DD8E31-F2CE-4151-8209-A24066162389</gtr:id><gtr:impact>More collaboration is on going</gtr:impact><gtr:outcomeId>56df571474d821.27672139-2</gtr:outcomeId><gtr:partnerContribution>provide powders and meetings and cash</gtr:partnerContribution><gtr:piContribution>pharmaceutical powder dispensing trial and 3D printing of PEEK</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>GlaxoSmithKline (GSK)</gtr:collaboratingOrganisation><gtr:country>Global</gtr:country><gtr:description>GSK</gtr:description><gtr:id>A2F53ACB-870D-4D51-B181-111665EB86D6</gtr:id><gtr:impact>More collaboration is on going</gtr:impact><gtr:outcomeId>56df571474d821.27672139-1</gtr:outcomeId><gtr:partnerContribution>provide powders and meetings and cash</gtr:partnerContribution><gtr:piContribution>pharmaceutical powder dispensing trial and 3D printing of PEEK</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs><gtr:impactSummaryOutput><gtr:description>The funding has been used to further develop the micro dry powder dispensing technology for pharmaceutical powder applications. A spin off company has been established.</gtr:description><gtr:firstYearOfImpact>2010</gtr:firstYearOfImpact><gtr:id>51EACD52-CDCB-4C1F-989F-34AB4053DEFD</gtr:id><gtr:impactTypes><gtr:impactType>Societal,Economic</gtr:impactType></gtr:impactTypes><gtr:outcomeId>56dccec0b69de5.47313899</gtr:outcomeId><gtr:sector>Aerospace, Defence and Marine,Agriculture, Food and Drink,Chemicals,Construction,Creative Economy,Electronics,Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:impactSummaryOutput></gtr:impactSummaryOutputs><gtr:intellectualPropertyOutputs><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5 mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200 ?m to 3 mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:id>9A65E793-AC9B-4769-91BD-BCC1972F48BE</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df5260400806.20355355</gtr:outcomeId><gtr:patentId>US 20120145806 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders US 20120145806 A1</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:id>12830C31-202F-49D3-9C1C-F1FC2EABF0C5</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df536019e365.07798739</gtr:outcomeId><gtr:patentId>GB 2472817 A</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:id>DCF564EA-2E72-4AF0-AC2C-80E09E62B7C4</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df50080f91f3.63249762</gtr:outcomeId><gtr:patentId>EP 2467681 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput><gtr:intellectualPropertyOutput><gtr:description>Apparatus for dispensing a powder, comprises a dispensing nozzle having an upper portion for containing a quantity of the powder, having a minimum internal horizontal dimension of 5mm, and a dispensing orifice below the upper portion, with a maximum internal horizontal dimension of from 200?m to 3mm. An internal passage leading from the said upper portion to the dispensing orifice tapers in a linear manner from its upper end to its lower end. The apparatus includes a transducer for applying vibrational pulses to the dispensing nozzle, to dispense doses of powder from the orifice. Vibrational pulses are controlled to control flow of powder through the nozzle.</gtr:description><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:id>043538A8-A0EF-42E4-B38E-59EAAE8BF07A</gtr:id><gtr:impact>sales generated</gtr:impact><gtr:licensed>Yes</gtr:licensed><gtr:outcomeId>56df5072af3516.07560493</gtr:outcomeId><gtr:patentId>WO 2011020862 A1</gtr:patentId><gtr:protection>Patent application published</gtr:protection><gtr:title>Apparatus and method for dispensing powders</gtr:title></gtr:intellectualPropertyOutput></gtr:intellectualPropertyOutputs><gtr:keyFindingsOutput><gtr:description>Further development of this novel dry powder micro dispensing device on various pharmaceutical powders have been conducted using this grant. A large number of pharmaceutical companies were contacted and a spin off companies called VaryDose were established. There were some sales. However due to the difficulties of the management team to secure enough investment, the development is slow.</gtr:description><gtr:exploitationPathways>Similar ideas have been adopted and commercialized by a German company who has marketed it as a new benchmark of pharmaceutical powder handling, due to lack of money for patent protection. Further development on 3D printing application has lead to more research and academic and commercial interests.</gtr:exploitationPathways><gtr:id>B47D6C76-F8AB-4F54-ACD5-C0AFB560F255</gtr:id><gtr:outcomeId>56dcce174b4a52.33790275</gtr:outcomeId><gtr:sectors><gtr:sector>Aerospace, Defence and Marine,Agriculture, Food and Drink,Chemicals,Construction,Creative Economy,Education,Electronics,Energy,Environment,Healthcare,Leisure Activities, including Sports, Recreation and Tourism,Manufacturing, including Industrial Biotechology,Culture, Heritage, Museums and Collections,Pharmaceuticals and Medical Biotechnology,Security and Diplomacy,Transport</gtr:sector></gtr:sectors><gtr:url>http://varydose.com/</gtr:url></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs><gtr:spinOutOutput><gtr:companyName>VaryDose Ltd</gtr:companyName><gtr:description>The company was spin out to commercialization the dry powder micro dispensing technology on pharmaceutical application.</gtr:description><gtr:id>C99183A3-8DE0-49F0-97A0-BAF6E6D70564</gtr:id><gtr:impact>Application of the dry powder micro dispensing technology on pharmaceutical powders have been demonstrated. Great interests from pharmaceutical companies have been seen.</gtr:impact><gtr:outcomeId>56df20ab6e0cb5.04096362</gtr:outcomeId><gtr:url>http://www.varydose.com</gtr:url><gtr:yearCompanyFormed>2010</gtr:yearCompanyFormed></gtr:spinOutOutput></gtr:spinOutOutputs></gtr:output><gtr:publications><gtr:publication><gtr:id>CB325A9A-1280-41BD-AD47-5DC0F088A629</gtr:id><gtr:title>On the bridging mechanism in vibration controlled dispensing of pharmaceutical powders from a micro hopper</gtr:title><gtr:parentPublicationTitle>Powder Technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e22a94e0024bfaaaef288c9d2e81f3bf"><gtr:id>e22a94e0024bfaaaef288c9d2e81f3bf</gtr:id><gtr:otherNames>Jasion G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:outcomeId>56df4aa5a6b3b7.98112847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BC7A089-D042-451C-9BF5-3D91E877ABE7</gtr:id><gtr:title>The control of microdispensed mean dose of inhalac70 by varying the time period of vibration in an acoustic micro-dosing system</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_2488375747cac7d0a0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>489C4CE5-A1F7-4979-8F65-0480DD099151</gtr:id><gtr:title>The role of nozzle size of an acoustic vibration controlled micro-dosing system on micro-dispensing of inhalac70</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_9660595011cac82bc2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7C2DAA2D-7251-4BF9-847F-5EF86BAD289C</gtr:id><gtr:title>The effect of signal amplitude of an ultrasonic vibration controlled metering device on micro-dispensing of inhalation grade lactose</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/feca0ea30d543cacc41a19f8a5987a75"><gtr:id>feca0ea30d543cacc41a19f8a5987a75</gtr:id><gtr:otherNames>Prashant Balani</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:outcomeId>r_3444549581cac7eb80</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">EP/H502319/1</gtr:identifier></gtr:identifiers><gtr:projectHierarchy><gtr:parents><gtr:parent><gtr:id>3B1E3AAB-D2E6-410C-A06C-E8CA1788E272</gtr:id><gtr:grantRef>EP/H502319/1</gtr:grantRef><gtr:amount>81014.17</gtr:amount><gtr:start>2010-06-01</gtr:start><gtr:end>2010-09-01</gtr:end><gtr:children><gtr:child rel="Transfer"><gtr:id>EB5F6743-E5BD-44D8-A06B-8E8152AAE048</gtr:id><gtr:grantRef>EP/H502319/2</gtr:grantRef><gtr:amount>62615.38</gtr:amount><gtr:start>2010-09-01</gtr:start><gtr:end>2011-08-31</gtr:end><gtr:children/></gtr:child></gtr:children></gtr:parent></gtr:parents></gtr:projectHierarchy><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects><gtr:researchSubject><gtr:id>60EBB420-734E-4DB5-B0F2-65A1115A27F8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Chemical synthesis</gtr:text></gtr:researchSubject><gtr:researchSubject><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchSubject></gtr:researchSubjects><gtr:researchTopics><gtr:researchTopic><gtr:id>B30DC286-3309-48E2-A15D-BDF547057A33</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Drug Formulation &amp; Delivery</gtr:text></gtr:researchTopic><gtr:researchTopic><gtr:id>D513F43E-F19D-4AB3-8E03-A47B085709AB</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Materials Processing</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>